Treatment of pediatric anxiety disorders

被引:8
|
作者
Rapp, Amy [1 ]
Dodds, Alice [2 ]
Walkup, John T. [3 ,4 ]
Rynn, Moira [1 ]
机构
[1] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] NewYork Presbyterian Hosp, New York, NY USA
来源
关键词
cognitive behavioral therapy; pharmacotherapy; pediatric; anxiety; COGNITIVE-BEHAVIORAL THERAPY; POSTTRAUMATIC-STRESS-DISORDER; OBSESSIVE-COMPULSIVE DISORDER; RANDOMIZED CONTROLLED-TRIAL; ANTIGLUTAMATERGIC AGENT RILUZOLE; TRAUMA-FOCUSED CBT; OPEN-LABEL TRIAL; D-CYCLOSERINE; DOUBLE-BLIND; MEMANTINE AUGMENTATION;
D O I
10.1111/nyas.12318
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., D-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.
引用
收藏
页码:52 / 61
页数:10
相关论文
共 50 条
  • [1] Psychopharmacologic treatment of pediatric anxiety disorders
    Reinblatt, SP
    Walkup, JI
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2005, 14 (04) : 877 - +
  • [2] PSYCHOPHARMACOLOGIC TREATMENT OF PEDIATRIC ANXIETY DISORDERS
    Strawn, Jeffrey R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S85 - S85
  • [3] Pharmacological Treatment for Pediatric Anxiety Disorders
    Wesemann, Daniel
    [J]. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2022, 60 (09) : 6 - 9
  • [4] Neurobiology of Treatment in Pediatric Anxiety Disorders
    Baumel, W. Thomas
    Strawn, Jeffrey R.
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2023, 32 (03) : 589 - 600
  • [5] Psychopharmacologic Treatment for Pediatric Anxiety Disorders
    Peters, Todd E.
    Connolly, Sucheta
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2012, 21 (04) : 789 - +
  • [6] Pharmacologic Treatment of Pediatric Anxiety Disorders
    Hussain F.S.
    Dobson E.T.
    Strawn J.R.
    [J]. Current Treatment Options in Psychiatry, 2016, 3 (2) : 151 - 160
  • [7] PSYCHOPHARMACOLOGIC TREATMENT OF PEDIATRIC ANXIETY DISORDERS: AN UPDATE
    Strawn, Jeffrey Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S130 - S130
  • [8] fMRI predictors of treatment outcome in pediatric anxiety disorders
    McClure, Erin B.
    Adler, Abby
    Monk, Christopher S.
    Cameron, Jennifer
    Smith, Samantha
    Nelson, Eric E.
    Leibenluft, Ellen
    Ernst, Monique
    Pine, Daniel S.
    [J]. PSYCHOPHARMACOLOGY, 2007, 191 (01) : 97 - 105
  • [9] Treatment for Anxiety Disorders in the Pediatric Primary Care Setting
    Blossom, Jennifer B.
    Jungbluth, Nathaniel
    Dillon-Naftolin, Erin
    French, William
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2023, 32 (03) : 601 - 611
  • [10] fMRI predictors of treatment outcome in pediatric anxiety disorders
    Erin B. McClure
    Abby Adler
    Christopher S. Monk
    Jennifer Cameron
    Samantha Smith
    Eric E. Nelson
    Ellen Leibenluft
    Monique Ernst
    Daniel S. Pine
    [J]. Psychopharmacology, 2007, 191 : 97 - 105